Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Open Biology|March 15, 2021
m6A methylation potentiates cytosolic dsDNA recognition in a sequence-specific mannerMelania Balzarolo, Sander Engels, Anja J de Jong, et al.
Cancers|September 10, 2021
CD47-SIRPα Checkpoint Inhibition Enhances Neutrophil-Mediated Killing of Dinutuximab-Opsonized Neuroblastoma CellsPaula Martínez-Sanz, Arjan J Hoogendijk, Paul J J H Verkuijlen, et al.
Frontiers in Immunology|March 27, 2023
Humanized MISTRG as a preclinical in vivo model to study human neutrophil-mediated immune processesPaula Martinez-Sanz, Adrien R G Laurent, Edith Slot, et al.
Cancer Immunology Research|November 7, 2019
IgA-Mediated Killing of Tumor Cells by Neutrophils Is Enhanced by CD47-SIRPα Checkpoint InhibitionLouise W Treffers, Toine Ten Broeke, Thies Rösner, et al.
Frontiers in Immunology|November 9, 2020
SIRPα on Mouse B1 Cells Restricts Lymphoid Tissue Migration and Natural Antibody ProductionKatka Franke, Saravanan Y Pillai, Mark Hoogenboezem, et al.
Journal for Immunotherapy of Cancer|May 29, 2021
G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatmentPaula Martinez Sanz, Dieke J van Rees, Lieke M J van Zogchel, et al.
Frontiers in Immunology|February 15, 2019
FcγRIIIb Restricts Antibody-Dependent Destruction of Cancer Cells by Human NeutrophilsLouise W Treffers, Michel van Houdt, Christine W Bruggeman, et al.
Nature Medicine|March 6, 2019
Glutaminyl cyclase is an enzymatic modifier of the CD47- SIRPα axis and a target for cancer immunotherapyMeike E W Logtenberg, J H Marco Jansen, Matthijs Raaben, et al.
Cell Reports|June 28, 2018
Neutrophils Kill Antibody-Opsonized Cancer Cells by TrogoptosisHanke L Matlung, Liane Babes, Xi Wen Zhao, et al.
Pageof 2